Anticancer Effects of Beta-Lapachone
Abstract
Full Text:
PDFReferences
M.-T. Park, M.-J. Song, H. Lee, E.-T. Oh, B.-H. Choi, et al. Beta-lapachone significantly increases the effect of ionizing radiation to cause mitochondrial apoptosis via JNK activation in cancer cells, PLoS One. 2011; 6(10): e25976p. doi: 10.1371/journal.pone.0025976.
J.B. Schulz, D. Bremen, J.C. Reed, J. Lommatzsch, S. Takayama, et al. Cooperative interception of neuronal apoptosis by BCL-2 and BAG1expression: prevention of caspase activation and reduced production of reactive oxygen species, J Neurochem. 1997; 69: 2075–86p.
M.T. Park, M.J. Kim, Y.H. Kang, S.Y. Choi, J.H. Lee, et al. Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release, Blood. 2005; 105: 1724–33p.
Y.H. Kang, M.J. Yi, M.J. Kim, M.T. Park, S. Bae, et al. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis inducing factor release from mitochondria, Cancer Res. 2004; 64: 8960–7p.
V. Goossens, K. De Vos, D. Vercammen, M. Steemans, K. Vancompernolle, et al. Redox regulation of TNF signaling, Biofactors. 1999; 10: 145–56p.
N.S. Chandel, P.T. Schumacker, R.H. Arch. Reactive oxygen species are downstream products of TRAF-mediated signal transduction, J Biol Chem. 2001; 276: 42728–36p.
Y.C. Lien, H.N. Kung, K.S. Lu, C.J. Jeng, Y.P. Chau. Involvement of endoplasmic reticulum stress and activation of MAP kinases in beta-lapachone induced human prostate cancer cell apoptosis, Histol Histopathol. 2008; 23: 1299–1308p.
T.J. Liu, S.Y. Lin, Y.P. Chau. Inhibition of poly (ADP-ribose) polymerase activation attenuates beta-lapachone-induced necrotic celldeath in human osteosarcoma cells, Toxicol Appl Pharmacol. 2002; 182: 116–25p.
E.A. Bey, M.S. Bentle, K.E. Reinicke, Y. Dong, C.R. Yang, et al. An NQO1- and PARP-1-mediated cell death pathway induced in non-small cell lung cancer cells by beta-lapachone, Proc Natl Acad Sci U S A. 2007; 104: 11832–7p.
G. Middleton, P. Ghaneh, E. Costello, W. Greenhalf, J.P. Neoptolemos. New treatment options for advanced pancreatic cancer, Expert Rev Gastroenterol Hepatol. 2008; 2: 673–96p.
E.A. Bey, K.E. Reinicke, M.C. Srougi, M. Varnes, V.E. Anderson, et al. Catalase abrogates β-lapachone-induced PARP1 hyperactivationdirected programmed necrosis in NQO1-positive breast cancers, Mol Cancer Ther. 2013; 12: 2110–20p.
E. Blanco, E.A. Bey, C. Khemtong, S.G. Yang, J. Setti-Guthi, et al. Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy, Cancer Res. 2010; 70: 3896–904p.
Y.Z. Li, C.J. Li, A.V. Pinto, A.B. Pardee. Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells, Mol Med. 1999; 5: 232–9p.
E.J. Park, K.S. Choi, T.K. Kwon. β-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells, Chem Biol Interact. 2011; 189: 37–44p.
Y.P. Chau, S.G. Shiah, M.J. Don, M.L. Kuo. Involvement of hydrogen peroxide in topoisomerase inhibitor beta-lapachone-induced apoptosis and differentiation in human leukemia cells, Free Radic Biol Med. 1998; 24: 660–70p.
J.J. Pink, S.M. Planchon, C. Tagliarino, M.E. Varnes, D. Siegel, et al. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity, J Biol Chem. 2000; 275: 5416–24p.
S.M. Planchon, J.J. Pink, C. Tagliarino, W.G. Bornmann, M.E. Varnes, et al. Beta-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3, Exp Cell Res. 2001; 267: 95–106p.
C.C. Lai, T.J. Liu, L.K. Ho, M.J. Don, Y.P. Chau. beta-Lapachone induced cell death in human hepatoma (HepA2) cells, Histol Histopathol. 1998; 13: 89–97p.
M.J. Don, Y.H. Chang, K.K. Chen, L.K. Ho, Y.P. Chau. Induction of CDK inhibitors (p21(WAF1) and p27(Kip1)) and Bak in the betalapachone- induced apoptosis of human prostate cancer cells, Mol Pharmacol. 2001; 59: 784–94p.
Y.C. Lien, H.N. Kung, K.S. Lu, C.J. Jeng, Y.P. Chau. Involvement of endoplasmic reticulum stress and activation of MAP kinases in betalapachone- induced human prostate cancer cell apoptosis, Histol Histopathol. 2008; 23: 1299–308p.
H.N. Kung, T.Y. Weng, Y.L. Liu, K.S. Lu, Y.P. Chau. Sulindac compounds facilitate the cytotoxicity of β-lapachone by up-regulation of NAD(P)H quinone oxidoreductase in human lung cancer cells, PLoS One. 2014; 9: e88122.
N.V. De Witte, A.O. Stoppani, M. Dubin. 2-Phenyl-beta-lapachone can affect mitochondrial function by redox cycling mediated oxidation, Arch Biochem Biophys. 2004; 432: 129–35p.
C. Tagliarino, J.J. Pink, G.R. Dubyak, A.L. Nieminen, D.A. Boothman. Calcium is a key signaling molecule in beta-lapachone-mediated cell death, J Biol Chem. 2001; 276: 19150–9p.
H. Lee, M.T. Park, B.H. Choi, E.T. Oh, M.J. Song, et al. Endoplasmic reticulum stress-induced JNK activation is a critical event leading to mitochondria-mediated cell death caused by β-lapachone treatment, PLoS One. 2011; 6: e21533p.
D.A. Boothman, S. Greer, A.B. Pardee. Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione), a novel DNA repair inhibitor, Cancer Res. 1987; 47: 5361–6p.
M.L. Smith, J.M. Ford, M.C. Hollander, R.A. Bortnick, S.A. Amundson, et al. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes, Mol Cell Biol. 2000; 20: 3705–14p.
K.K. Wong, S. Chang, S.R. Weiler, S. Ganesan, J. Chaudhuri, et al. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation, Nat Genet. 2000; 26: 85–8p.
D.A. Boothman, D.K. Trask, A.K. Pardee. Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I, Cancer Res. 1989; 49: 605–12p.
E.K. Choi, K. Terai, I.M. Ji, Y.H. Kook, K.H. Park, et al. Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells, Neoplasia. 2007; 9: 634–42p.
L.S. Li, E.A. Bey, Y. Dong, J. Meng, B. Patra, et al. Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy, Clin Cancer Res. 2011; 17: 275–85p.
X.L. Tan, G. Marquardt, A.B. Massimi, M. Shi, W. Han, et al. Highthroughput library screening identifies two novel NQO1 inducers in human lung cells, Am J Respir Cell Mol Biol. 2012; 46: 365–71p.
H. Satsu, E. Chidachi, Y. Hiura, H. Ogiwara, Y. Gondo, et al. Induction of NAD(P)H:quinone oxidoreductase 1 expression by cysteine via Nrf2 activation in human intestinal epithelial LS180 cells, Amino Acids. 2012; 43: 1547–55p.
CW Tsai, C.Y. Lin, Y.J. Wang. Carnosic acid induces the NAD(P)H: quinone oxidoreductase 1 expression in rat clone 9 cells through the p38/nuclear factor erythroid-2 related factor 2 pathway, J Nutr. 2011; 141: 2119–25p.
F.G. Bottone, J.M. Martinez, J.B. Collins, C.A. Afshari, T.E. Eling. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis, J Biol Chem. 2003; 278: 25790–801p.
K. Terai, G.Z. Dong, E.T. Oh, M.T. Park, Y. Gu, et al. Cisplatin enhances the anticancer effect of beta-lapachone by upregulating NQO1, Anticancer Drugs. 2009; 20: 901–9p.
S.B. Lee, K.H. Cha, D. Selenge, A. Solongo, C.W. Nho. The chemopreventive effect of taxifolin is exerted through ARE-dependent gene regulation, Biol Pharm Bull. 2007; 30: 1074–9p.
A.E. Wagner, I. Ernst, R. Iori, C. Desel, G. Rimbach. Sulforaphane but not ascorbigen, indole-3-carbinole and ascorbic acid activates the transcription factor Nrf2 and induces phase-2 and antioxidant enzymes in human keratinocytes in culture, Exp Dermatol. 2010; 19: 137–44p.
T. Hori, T. Kondo, H. Lee, C.W. Song, H.J. Park. Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells, Int J Hyperther. 2011; 27: 53–62p.
G.Z. Dong, Youn H, Park MT, Oh ET, Park KH, et al. (2009) Heat shock increases expression of NAD(P)H:quinone oxidoreductase (NQO1), 1
H.J. Park, E.K. Choi, J. Choi, K.J. Ahn, E.J. Kim, et al. Heat-induced upregulation of NAD(P)H:quinone oxidoreductase potentiates anticancer effects of beta-lapachone, Clin Cancer Res. 11: 8866–71p.
M.J. Lamberti, N.B. Vittar, C. da Silva Fde, V.F. Ferreira, V.A. Rivarola. Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1). Phytomedicine. 2013; 20: 1007–12p.
P. Tugwell, D. Ludwin, M. Gent, R. Roberts, W. Bensen, et al. Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs, J Rheumatol. 1997; 24: 1122–5p.
P. Tugwell, D. Ludwin, M. Gent, R. Roberts, W. Bensen, et al. Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs, J Rheumatol. 1997; 24: 1122–5p.
H.L. Muncie, Jr. Medical aspects of the multidisciplinary assessment and management of osteoarthritis, Clin Ther. 1986; 9 Suppl B: 4–13p.
Fernandes E, Toste SA, Lima JL, Reis S (2003) The metabolism of sulindac enhances its scavenging activity against reactive oxygen and nitrogen species. Free Radic Biol Med 35: 1008–1017. doi: 10.1016/s0891-5849(03)00437-4
G.N. Karachalios, G. Donas. Sulindac in the treatment of acute gout arthritis, Int J Tissue React. 1982; 4: 297–9p.
D.K. Klassen, R.L. Stout, P.S. Spilman, A. Whelton. Sulindac kinetics and effects on renal function and prostaglandin excretion in renal insufficiency, J Clin Pharmacol. 1989; 29: 1037–42p. doi: 10.1002/j.1552-4604. 1989.tb03275.x.
M.J. Thun, S.J. Henley, C. Patrono. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues, J Natl Cancer Inst. 2002; 94: 252–66p. doi: 10.1093/jnci/94.4.252.
C. Ruegg, J. Zaric, R. Stupp. Nonsteroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality, Ann Med. 2003; 35: 476–87p. doi: 10.1080/07853890310017053.
Hollander, P. M., and Ernster, L. (1975) Arch. Biochem. Biophys.169. 560–567
S. Hosoda, W. Nakamura, K. Hayashi. J Biol Chem. 1974; 249: 6416–23p.
J.J. Pink, S.M. Planchon, C. Tagliarino, M.E. Varnes, D. Siegeis, D.A. Boothman. NAD(P) H:Quinone oxidoreductase activity is the principle determinant of beta–lapachone cytotoxicity.
J.I. Lee, D.Y. Choi, H.S. Chung, H.G. Seo, H.J. Woo, B.T. Choi, Y.H. Choi. Beta-lapachone induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2 family and activation of caspases, Exp Oncol. 2006a; 28: 30–5p.
H.Y. Yu, S.O. Kim, C.-Y. Jin, W.-J. Kim, Y.H. Yoo, Y.H. Choi. Beta–lapachone-induce apoptosis of Huma gastric carcinoma AGS cells is caspase-dependent and Regulate by the P13K/AKT Pathway.
Inhibition of radiation –induce neoplastic transformation by beta-lapachone. Proc.Natl.Acad Sci.U S A 1987 Jul;86(13) :4963-7.
A. D'Anneo, G. Augello, A. Santulli, M. Giuliano, R. di Fiore, et al. Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt, J Cell Physiol. 2010; 222: 433–43p.
J. Kumi-Diaka. Chemosensitivity of human prostate cancer cells PC3 and LNCaP to genistein isoflavone and beta-lapachone, Biol Cell. 2002; 94: 37–44p.
H.N. Kung, K.S. Lu, Y.P. Chau The chemotherapeutic effects of lapacho tree extract: beta-lapachone, Chemotherapy. 2014; 3: 131p.
P. Krishnan, K.F. Bastow. Noval mechanism of topoisomerase II inhibition by pyranonphthoquinone derivatives–eleutherin, alpha–lapachone, beta-lapachone.
A. Carnero, C. Blanco-Aparicio, O. Renner, W. Link, J.F. Leal. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications, Curr Cancer Drug Targets. 2008; 8: 187–98p. J.J. Champoux. In: DNA Topology and Its Biological Effects. Wang J.C., Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1990.
J.C. Wang. Annu Reu Biochem. 1985; 54: 665–97p; Mediator of beta-lapachone cytotoxicity, by increasing NQO1 gene activity and via Hsp70-mediated stabilisation of NQO1 protein, Int J Hyperther. 25: 477–87p.
K.M. Tewev, G.L. Chem, E.M. Nelson, L.F. Liu, J Biol C m. 1984; 259: 9182–7p.
K.M. Tewev, T.C. Rowe, L. Yang, B.D. Halligan, L.F. Lin. Science. 1984; 226: 466–8p.
Y. Pommier, J.K. Minford, R.E. Schwartz, L.A. Zwelling, K.W. Khon. Biochemistry. 1985; 24: 6410–6p.
G.L. Chem, L. Yang, T.C. Rowe, B.D. Halligan, K.M. Tewey, L.F. Liu. J Biol Chem. 1985; 259: 13560–6p.
DOI: https://doi.org/10.37628/ijmb.v3i2.225
Refbacks
- There are currently no refbacks.